Skip to main content
Fig. 5 | BMC Public Health

Fig. 5

From: Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa

Fig. 5

AE notification scheme in Côte D’Ivoire. AIRP, l’Agence Ivoirienne de Régulation Pharmaceutique (Ivorian Pharmaceutical Regulatory Agency); CNPV, Centre National de la Pharmacovigilance (National Pharmacovigilance Center); DPML: Direction de la Pharmacie des Médicaments et des Laboratoires (Department of Pharmacy, Medicines and Laboratories); IPCI: Institut Pasteur de Côte d’Ivoire (Pasteur Institute of Côte d’Ivoire); LNSP: Laboratoire Nationale de Santé Publique (National Laboratory for Public Health); UMC, Uppsala Monitoring Centre; UTH, University Teaching Hospital; WHO, World Health Organization

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us